TITLE

NEUROPROTECTION

AUTHOR(S)
Serle, Jenet B.
PUB. DATE
January 2005
SOURCE
Ophthalmology Times;1/1/2005, Vol. 30 Issue 1, special section p5
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
This article reports that neuroprotection attempts to block the final common pathway of a variety of insults that lead to ganglion cell death. Numerous potential treatment modalities for neural protection have been under investigation. Some research has focused on stabilizing calcium homeostasis with beta adrenergic antagonists, particularly betaxolol. Ginkgo may potentially afford neuroprotection through a number of mechanisms, including altered blood flow to the optic nerve. Brimonidine has been studied in rats with a transected optic nerve. Results have shown that rats that received brimonidine treatment had more ganglion cells remaining than those that did not receive treatment.
ACCESSION #
15748368

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics